Launching October 2026

Long COVID FAQs

FAQs About Long COVID

Long COVID often raises just as many questions as the condition itself. From wondering why symptoms persist after the initial infection to understanding available treatment options, pacing strategies, medications, and what recovery may look like, it’s common to have questions throughout your care.

This FAQ answers many of the questions our providers hear most often. While every treatment plan is personalized, these answers can help you better understand Long COVID, what to expect during evaluation and treatment, and when you should contact your healthcare provider.

Yes. Long COVID is recognized as an infection-associated chronic condition that can affect one or more organ systems and can cause substantial disability.

No. A prior positive viral or antibody test can support the history but is not required for a clinical Long COVID diagnosis, especially when testing was unavailable or falsely negative.

Persistent symptoms after vaccination are being studied, and patients may also have a recognized vaccine-associated adverse event. Chronic PVS does not yet have universally accepted criteria or a validated diagnostic test. Evaluation should remain open to vaccination, prior infection, other medical causes, or overlapping factors.

Fatigue, PEM, brain fog, sleep disturbance, shortness of breath, palpitations, dizziness, headache, altered smell or taste, muscle or joint discomfort, digestive symptoms, and autonomic symptoms are common.

PEM is a delayed and disproportionate worsening after physical, cognitive, emotional, or sensory effort. It can last days or longer and should guide pacing and rehabilitation decisions.

They may contribute in a subset of patients, particularly when persistent viral material or antigen continues to stimulate immune or vascular pathways. They do not explain every case, and other mechanisms may be more important in many patients.

No current spike test is validated as a stand-alone diagnostic or severity test for routine care. High or detectable levels can occur without symptoms, and patients with low or undetectable blood levels can be very ill.

Not necessarily. Some patients improve as antigen markers decrease; others do not. Downstream immune, vascular, autonomic, neurologic, metabolic, or tissue changes can persist independently.

Long COVID likely contains multiple biological subtypes. A therapy that helps histamine symptoms may not correct dysautonomia, and an anti-inflammatory approach may not resolve tissue injury or PEM.

That has not been demonstrated in high-quality human clinical trials. Binding and anti-inflammatory theories are mainly laboratory or mechanistic hypotheses. Ivermectin is not a validated spike-detox medication.

Some clinicians and patients report benefit, but controlled evidence for established Long COVID is insufficient. Trials in acute COVID have generally not shown meaningful benefit, and early ivermectin did not reduce later Long COVID diagnoses in a major randomized trial.

Hydroxychloroquine has immunomodulatory and lysosomal effects that create a theoretical rationale for selected inflammatory or autoimmune-like phenotypes. However, controlled evidence has not established that it improves Long COVID, and acute-COVID trials did not show meaningful clinical benefit. Cardiac rhythm, retinal, hypoglycemia, interaction, and cumulative-toxicity risks require careful selection and monitoring.

No. Laboratory theories involving endosomes, lysosomes, ACE2 processing, or viral entry do not demonstrate that hydroxychloroquine removes circulating or tissue spike protein in patients.

LDN is used off label in an attempt to reduce neuroinflammatory signaling, discomfort, fatigue, sleep disruption, or brain fog. Early studies are promising but not conclusive.

LDN must not be combined with opioid medications without specialized planning. It can block opioid pain relief or precipitate withdrawal.

Not when activity triggers PEM. Pacing aims to stay within the patient’s current energy envelope. Rehabilitation should be symptom-titrated and should not repeatedly provoke prolonged crashes.

Some patients with hives, flushing, itching, food sensitivity, nasal symptoms, or histamine-like flares report benefit from H1/H2 blockade. Evidence is limited, and long-term medication risks still matter.

Not automatically. These can cause serious bleeding. Anticoagulation should be used for a conventional indication or within specialist/research care—not solely because Long COVID is suspected.

No supplement has been proven to cure Long COVID. Correcting deficiencies and selected symptom-directed adjuncts may help, but products can interact with medication or cause toxicity.

Testing is selected by symptoms and may include blood counts, metabolic and thyroid tests, iron, B12/folate, inflammation markers, liver/kidney tests, ECG, orthostatic vitals, cardiac or pulmonary testing, sleep evaluation, or other targeted studies. There is no universal panel.

Yes. Many patients improve over time, although recovery may be slow or uneven. Early symptom management, pacing, prevention of reinfection, treatment of complications, sleep and nutritional support, and appropriate accommodations can help.

Seek urgent care for severe chest symptoms, new trouble breathing, low oxygen, fainting, stroke-like symptoms, sustained dangerous heart rhythm, major bleeding, severe dehydration, suicidal thoughts, or rapidly worsening illness.

How APNS Supports Patients

APNS uses a patient-centered, multifaceted approach: listening to the illness timeline, identifying dominant symptom patterns, excluding urgent and alternative conditions, reviewing medication risks, treating established complications, and discussing evidence-based, symptom-directed, and selected off-label options. Treatment response is monitored using specific goals rather than assuming one mechanism explains every symptom.

Patient Notice

This information is educational and does not diagnose Long COVID, establish that vaccination caused an illness, or authorize self-treatment. Medication and supplement decisions require individualized clinical review. Emergency symptoms require immediate in-person care.

Ready to take control of Long COVID?

Whether you’re experiencing persistent symptoms after COVID-19 or looking for additional support after months or years of ongoing illness, APNS is here to help. Our providers will work with you to develop a personalized evaluation and treatment plan based on your symptoms, medical history, and individual needs, with the goal of improving function, quality of life, and long-term health.